期刊文献+

认知心理干预对抑郁症患者的影响 被引量:2

Effects of cognitive psychotherapy on depression patients
下载PDF
导出
摘要 目的:探讨认知心理对抑郁症患者的影响。方法:选择70例抑郁症患者为研究对象,随机分为观察组和对照组,每组各35例。两组患者均给予盐酸帕罗西汀联合富马酸喹硫平药物口服治疗12周;观察组患者在此基础上给予认知心理干预。比较治疗前、后,两组患者的汉密顿抑郁量表(HAMD)得分和汉密尔顿焦虑量表得分(HAMA)变化及GQOLI-74生活质量量表评价患者生活质量。结果:治疗后,观察组患者的HAMD、HAMA得分均明显低于对照组(P<0.05),而心理功能与社会功能得分均显著高于对照组水平(P<0.05)。结论:在盐酸帕罗西汀联合富马酸喹硫平药物治疗抑郁症患者的基础上,采用认知心理干预有助于患者的抑郁、焦虑程度和促进其认知功能恢复。 Objective: To explore effects of cognitive psychotherapy on depression patients. Methods: 70 cases of depression were selected and randomly divided into observation group ( n = 35) and control group ( n = 35). Both groups were treated with Paroxe-tine hydrochloride combined with Quetiapine fumarate for 12 weeks. The observation group was given cognitive psychological intervention treatment at the same time. The Hamilton depression scale (HAMD) score and the Hamilton anxiety scale (HAMA) score were compared before and after the treatment between the two groups, meanwhile, the quality of life of the patients was evaluated by GQOLI -74. Results: After the treatment, the HAMD and HAMA scores of the observation group were significantly lower than those of the control group (P 〈0.05) ; however, the scores of psychological function and social function of the observation group were significantly higher than those of the control group ( P 〈0. 05). Conclusions: Based on Paroxetine hydrochloride combined with Quetiapine fumarate treatment, the cognitive psychotherapy can effectively improve depression and anxiety degrees in the patients with depression, and promote the recovery of cognitive function.
作者 赵绍锋 ZHAO Shaofeng(The Eighth People's Hospital of Zhengzhou, Zhengzhou Henan 450000, Chin)
出处 《中国民康医学》 2017年第7期59-60,共2页 Medical Journal of Chinese People’s Health
关键词 认知心理 抑郁症 疗效 Cognitive psychology Depression Curative effect
  • 相关文献

参考文献3

二级参考文献52

  • 1朱羞阳,佟洋,李驰荣.选择性5-羟色胺再摄取抑制剂与奥氮平联合治疗难治性抑郁症的临床疗效[J].东南国防医药,2013,15(2):125-127. 被引量:11
  • 2高代林,徐佳军,舒建明,等.文拉法辛联合认知行为治疗对难治性抑郁症疗效的影响因素研究[C].中华医学会第十次全国精神医学学术会议论文汇编,2012:76-77.
  • 3乐发国,范征莉,夏明,等.艾司西酞普兰联合改良电休克治疗难治性抑郁症随机双盲对照研究[C].中华医学会精神病学分会第九次全国学术会议论文集,2011:34-35.
  • 4Naismith SL, Hickie IB, Turner K, et al. Neuropsychological performance in patients with depression is associated with clinical,etiological and genetic risk factors [ J ]. J Clin Exp Neuropsychol,2003,25 (6) : 866 - 877.
  • 5Belanoff JK, Kalehzan M, Sund B, et al Cortisol activity and cognitive changes in psychotic major depression[ J]. Am J Psychiatry, 2001,158 (10) : 1612 - 1616.
  • 6Merriam EP, Thase ME, Haas GL. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance[J]. Am J Psychiatry, 1999, 156 (5) : 780 - 782.
  • 7Fossati P, Ergis AM, Allilaire JF. Executive functioning in unipolar depression: a review [ J ]. Encephale, 2002, 28 (2) : 97 -107.
  • 8战玉华,韩继阳,夏静,等.喹硫平联合文拉法辛及文拉法辛治疗躯体形式障碍比较[C].中华医学会精神病学分会第九次全国学术会议论文,2011:54-55.
  • 9邢葆平,李晓一,吴皓等.文拉法辛合并喹硫平治疗难治性抑郁症临床观察[C].2013年浙江省医学会精神病学分会学术年会暨浙江省医师协会精神科医生分会第六届年会论文汇编,2013:24-25.
  • 10Murphy JA, Byrne GJ. Prevalence and correlates of the pro- posed DSM-5 diagnosis of chronic depressive disorder. Journal of Affective Disorders, 2012, 139(2): 172-180.

共引文献45

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部